Roche strikes an €87.5M discovery deal with Confo; Onconova out-licenses preclinical drug to China's HanX
→ Belgian biotech Confo Therapeutics is getting some significant support from Roche. The pharma giant is supplying €6 million over the next 30 months …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.